Xconomy
Conferences, News, Syndication, Xconomy »
Zillions of Biotech Conferences Want You. Which Should You Attend? |  |
|
Posted by sandiegobiotech May 20th, 2013 .
| |
| No Comments |
Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches,…
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More | |
|
Posted by sandiegobiotech May 17th, 2013 .
| |
| No Comments |
[Clarification 5/17/13, 2:05 pm. See below.] Right on the same line with the original lede so you don’t waste space on a carriage return…Antibody drugs seemed to be the topic of the week…
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
Ambit Slices Price of IPO, Increases Number of Shares Offered | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering….
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
Ambit Slices Price of IPO, Increases Number of Shares Offered | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering….
[[Click headline to continue reading.]]
News, Syndication, Xconomy »
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) | |
|
Posted by sandiegobiotech May 14th, 2013 .
| |
| No Comments |
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of…
[[Click headline to continue reading.]]
More...News, Syndication, Xconomy »
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) | |
|
Posted by sandiegobiotech May 13th, 2013 .
| |
| No Comments |
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could…
[[Click headline to continue reading.]]
More...News, Syndication, Xconomy »
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More | |
|
Posted by sandiegobiotech May 9th, 2013 .
| |
| No Comments |
Amid the hectic pace of earnings releases, we saw a number of partnership agreements and other developments coming out of San Diego’s life sciences community. Here’s my wrap-up. —Shares of San…
[[Click headline to continue reading.]]
Drug Development, News, Syndication, Xconomy »
San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts | |
|
Posted by sandiegobiotech May 6th, 2013 .
| |
| No Comments |
[Corrected 5/6/13, 10:50 am. See below.] San Diego-based Receptos, a biotech developing new treatments for immune disorders, is among 13 IPOs expected to go public this week, according to Renaissance…
[[Click headline to continue reading.]]
More...News, Syndication, Xconomy »
Lessons For Drug Development From The Aveo Buzzsaw | |
|
Posted by sandiegobiotech May 6th, 2013 .
| |
| No Comments |
Drug development is a tough business. Small companies that dare to try often end up in public train wrecks when they head to Washington to meet the FDA. It’s a shame, a colossal waste, every time a…
[[Click headline to continue reading.]]
Drug Development, News, Syndication, Xconomy »
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration | |
|
Posted by sandiegobiotech May 2nd, 2013 .
| |
| No Comments |
Abide Therapeutics, a two-year-old San Diego biopharmaceutical firm pioneering new ways to identify and validate drug targets among the serine hydrolase “superfamily” of enzymes, says today it has…
[[Click headline to continue reading.]]
